December 31, 2025 · Form 4 insider transaction
Clifton R. LaDuane sold 20,000 shares of KemPharm Incorporated at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 7 days after the transaction.
Each performance stock unit represents a contingent right to receive one share of the Issuer's common stock.; The vesting of all restricted stock units and performance stock units was accelerated upon the Reporting Person's departure from the Company on December 31, 2025.